Keros Therapeutics (KROS) Cash & Equivalents Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -48.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48.67% |
| Sep 30, 2025 | 30.68% |
| Jun 30, 2025 | 70.06% |
| Mar 31, 2025 | 62.86% |
| Dec 31, 2024 | 69.09% |
| Sep 30, 2024 | 84.33% |
| Jun 30, 2024 | 26.03% |
| Mar 31, 2024 | 25.90% |
| Dec 31, 2023 | 18.67% |
| Sep 30, 2023 | 20.24% |
| Jun 30, 2023 | 49.35% |
| Mar 31, 2023 | 53.74% |
| Dec 31, 2022 | 21.30% |
| Sep 30, 2022 | 8.17% |
| Jun 30, 2022 | -9.06% |
| Mar 31, 2022 | -10.43% |
| Dec 31, 2021 | -13.48% |
| Sep 30, 2021 | 65.42% |
| Jun 30, 2021 | 63.88% |
| Mar 31, 2021 | 368.11% |
| Dec 31, 2020 | 3,687.41% |
| Sep 30, 2020 | 967.75% |
| Jun 30, 2020 | 830.64% |
| Mar 31, 2020 | 162.79% |